CD207 and chronic obstructive pulmonary disease: Analysis of osteopontin mRNA levels in the 7 control and 27 COPD tissues used to determine CD207 mRNA levels, did not show a significant difference between controls and COPD (0.188 ± 0.14 vs 0.297 ± 0.15 respectively, p = 0.17).